Bayesian Capital Management’s NOV NOV Stock Holding History

Bayesian Capital Management’s Portfolio NOV Stock Details NOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$255K	Buy	+13,738	New	+$274K	0.16%	173
2025 Q4	–	Sell	-21,100	Closed	-$280K	–	396
2025 Q3	$280K	Sell	21,100 -7,500	-26%	-$96.9K	0.06%	394
2025 Q2	$355K	Buy	+28,600	New	+$360K	0.06%	355
2022 Q2	–	Sell	-18,700	Closed	-$367K	–	982
2022 Q1	$367K	Buy	+18,700	New	+$327K	0.05%	466
2021 Q4	–	Sell	-23,200	Closed	-$304K	–	473
2021 Q3	$304K	Buy	+23,200	New	+$313K	0.09%	263
2021 Q2	–	Sell	-10,217	Closed	-$140K	–	572
2021 Q1	$140K	Buy	+10,217	New	+$148K	0.03%	481
2020 Q4	–	Sell	-56,300	Closed	-$510K	–	606
2020 Q3	$510K	Buy	56,300 +13,400	+31%	+$157K	0.12%	221
2020 Q2	$526K	Sell	42,900 -60,900	-59%	-$748K	0.12%	232
2020 Q1	$1.02M	Buy	+103,800	New	+$1.96M	0.22%	128
2019 Q3	–	Sell	-23,000	Closed	-$511K	–	630
2019 Q2	$511K	Buy	+23,000	New	+$556K	0.11%	260
2018 Q2	–	Sell	-8,400	Closed	-$309K	–	675
2018 Q1	$309K	Buy	+8,400	New	+$308K	0.08%	388
2017 Q4	–	Sell	-9,051	Closed	-$323K	–	664
2017 Q3	$323K	Buy	+9,051	New	+$296K	0.08%	348

Other funds holding NOV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Bayesian Capital Management's NOV Position: Q2 2026 in Review

Bayesian Capital Management opened a new position in NOV (NOV) in Q2 2026: 13,738 shares worth $255K. The stake represents 0.16% of the portfolio and ranks #173 among its holdings. This is a return to the name: Bayesian Capital Management previously reported a position in NOV as recently as Q3 2025.

Bayesian Capital Management first reported a position in NOV in Q3 2017 and has held it in 12 quarters since. The position peaked at $1.02M in Q1 2020. 489 funds tracked by Wall St. Rank hold NOV as of Q2 2026.

Bayesian Capital Management held 13,738 shares of NOV worth $255K as of Q2 2026.
NOV was a new Bayesian Capital Management position in Q2 2026.
NOV made up 0.16% of Bayesian Capital Management's portfolio in Q2 2026, its #173 holding.
Bayesian Capital Management first reported a position in NOV in Q3 2017 and has held it in 12 quarters since.
Bayesian Capital Management's NOV position peaked at $1.02M in Q1 2020.
489 funds tracked by Wall St. Rank held NOV as of Q2 2026.

Based on Bayesian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.